Page last updated: 2024-11-04

tetracaine and Granulomatous Disease, Chronic

tetracaine has been researched along with Granulomatous Disease, Chronic in 1 studies

Tetracaine: A potent local anesthetic of the ester type used for surface and spinal anesthesia.
tetracaine : A benzoate ester in which 4-N-butylbenzoic acid and 2-(dimethylamino)ethanol have combined to form the ester bond; a local ester anaesthetic (ester caine) used for surface and spinal anaesthesia.

Granulomatous Disease, Chronic: A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dallegri, F1
Patrone, F1
Frumento, G1
Sacchetti, C1

Other Studies

1 other study available for tetracaine and Granulomatous Disease, Chronic

ArticleYear
Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms.
    Journal of the National Cancer Institute, 1984, Volume: 73, Issue:2

    Topics: Antibody-Dependent Cell Cytotoxicity; Aprotinin; Blood Glucose; Burkitt Lymphoma; Carmustine; Cell L

1984